Overweight children are more vulnerable to early-onset hypertension. Childhood obesity is driving a rise in high blood ...

Hypertension, commonly known as high blood pressure, is a major risk factor for cardiovascular diseases. It affects millions ...

SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...

A 65-year-old woman presents to her primary care provider with a chief complaint of "feeling winded" for the last 3 weeks.

SGLT2 inhibitor use is associated with a reduced risk of hyperkalemia and lower rates of renin-angiotensin-aldosterone system ...

Therapy should include either belimumab or a calcineurin inhibitor, plus one or more conventional medications such as ...

Hypertension is a major global health challenge, affecting millions and serving as a key risk factor for cardiovascular and renal diseases. While endocrine ...

SGLT2 Inhibitors Linked to Lower Hyperkalemia Risk and Improved RAASi Continuation suggests a new study published in the JAMA ...

A scientific statement regarding risk-based primary prevention of heart failure has been published by the American Heart Association.

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

The novel aldosterone inhibitor works, but longer-term safety data are needed before the drug might be approved.